NeuroPace (NPCE) Change in Receivables (2020 - 2026)
NeuroPace (NPCE) posted quarterly Change in Receivables of $108000.0 for Q1 2026, down 95.82% year-over-year from $2.6 million in Q1 2025, and up 142.02% quarter-over-quarter from -$257000.0 in Q4 2025.
NeuroPace (NPCE) Change in Receivables (2020 - 2026) Analysis & Trends
NeuroPace's Change in Receivables history runs 7 years deep, the most recent figure standing at $108000.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 95.82% year-over-year to $108000.0; the TTM figure through Mar 2026 stood at -$647000.0 (down 117.01% YoY), while the FY2025 annual figure was $1.8 million, up 241.42% from the prior year.
- Change in Receivables for Q1 2026 stood at $108000.0, up from -$257000.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.6 million in Q1 2025, with the low at -$1.9 million in Q2 2025.
- The 5-year median for Change in Receivables is $318000.0 (2024), against an average of $453823.5.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables soared 1115.46% in 2022, then plunged 383.55% in 2025.
- NeuroPace's Change in Receivables stood at -$392000.0 in 2022, then surged by 368.37% to $1.1 million in 2023, then rose by 22.53% to $1.3 million in 2024, then tumbled by 119.94% to -$257000.0 in 2025, then jumped by 142.02% to $108000.0 in 2026.
- Business Quant data shows NPCE's Change in Receivables at $108000.0 in Q1 2026, -$257000.0 in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | 141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 141,000.00 |
| Jun 30, 2026 | 141,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | -257,000.00 |
| Dec 31, 2025 | -257,000.00 |
| Sep 30, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 318,000.00 |
| Sep 30, 2024 | 318,000.00 |
| Jun 30, 2024 | -389,000.00 |
| Jun 30, 2024 | -389,000.00 |
| Mar 31, 2024 | -682,000.00 |
| Mar 31, 2024 | -682,000.00 |